| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥7.37B | ¥7.29B | +1.2% |
| Cost of Sales | ¥3.62B | ¥3.62B | +0.1% |
| Gross Profit | ¥3.75B | ¥3.67B | +2.2% |
| SG&A Expenses | ¥2.89B | ¥2.79B | +3.6% |
| Operating Income | ¥863M | ¥880M | -1.9% |
| Non-operating Income | ¥65M | ¥49M | +32.2% |
| Non-operating Expenses | ¥11M | ¥4M | +141.3% |
| Ordinary Income | ¥917M | ¥924M | -0.8% |
| Profit Before Tax | ¥916M | ¥925M | -1.0% |
| Income Tax Expense | ¥289M | ¥291M | -0.6% |
| Net Income | ¥627M | ¥634M | -1.2% |
| Net Income Attributable to Owners | ¥622M | ¥622M | +0.0% |
| Total Comprehensive Income | ¥860M | ¥791M | +8.7% |
| Depreciation & Amortization | ¥451M | ¥407M | +10.9% |
| Interest Expense | ¥7M | ¥2M | +239.6% |
| Basic EPS | ¥199.22 | ¥199.70 | -0.2% |
| Dividend Per Share | ¥35.00 | ¥35.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥13.69B | ¥13.78B | ¥-97M |
| Cash and Deposits | ¥10.79B | ¥10.63B | +¥168M |
| Accounts Receivable | ¥2.48B | ¥2.87B | ¥-396M |
| Inventories | ¥244M | ¥179M | +¥65M |
| Non-current Assets | ¥11.70B | ¥10.81B | +¥896M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥1.20B | ¥976M | +¥224M |
| Investing Cash Flow | ¥-1.03B | ¥-1.31B | +¥283M |
| Financing Cash Flow | ¥-401M | ¥-412M | +¥11M |
| Free Cash Flow | ¥169M | - | - |
| Item | Value |
|---|---|
| Net Profit Margin | 8.4% |
| Gross Profit Margin | 50.9% |
| Current Ratio | 328.1% |
| Quick Ratio | 322.3% |
| Debt-to-Equity Ratio | 0.30x |
| Interest Coverage Ratio | 128.65x |
| EBITDA Margin | 17.8% |
| Effective Tax Rate | 31.6% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +1.2% |
| Operating Income YoY Change | -1.9% |
| Ordinary Income YoY Change | -0.8% |
| Net Income Attributable to Owners YoY Change | -0.1% |
| Total Comprehensive Income YoY Change | +8.6% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 3.42M shares |
| Treasury Stock | 297K shares |
| Average Shares Outstanding | 3.12M shares |
| Book Value Per Share | ¥6,232.71 |
| EBITDA | ¥1.31B |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥35.00 |
| Year-End Dividend | ¥35.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| CareWelfareRelated | ¥582M | ¥60,000 |
| HomeMedicalTreatmentRelated | ¥3.55B | ¥431M |
| MedicalGasEquipmentInstallationRelated | ¥651M | ¥92M |
| MedicalGasRelated | ¥1.94B | ¥283M |
| NursingHome | ¥176M | ¥-2M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥15.26B |
| Operating Income Forecast | ¥2.07B |
| Ordinary Income Forecast | ¥2.14B |
| Net Income Attributable to Owners Forecast | ¥1.48B |
| Basic EPS Forecast | ¥472.57 |
| Dividend Per Share Forecast | ¥45.00 |
| Property, Plant & Equipment | ¥6.73B | ¥6.68B | +¥47M |
| Intangible Assets | ¥120M | ¥139M | ¥-19M |
| Investment Securities | ¥3.85B | ¥2.97B | +¥886M |
| Total Assets | ¥25.39B | ¥24.59B | +¥799M |
| Current Liabilities | ¥4.17B | ¥4.35B | ¥-180M |
| Accounts Payable | ¥2.45B | ¥2.75B | ¥-297M |
| Non-current Liabilities | ¥1.75B | ¥1.52B | +¥229M |
| Total Liabilities | ¥5.92B | ¥5.87B | +¥49M |
| Total Equity | ¥19.47B | ¥18.71B | +¥751M |
| Capital Stock | ¥436M | ¥436M | ¥0 |
| Capital Surplus | ¥570M | ¥570M | ¥0 |
| Retained Earnings | ¥17.85B | ¥17.34B | +¥513M |
| Treasury Stock | ¥-838M | ¥-838M | ¥-218,000 |
| Owners' Equity | ¥19.17B | ¥18.43B | +¥739M |
| Working Capital | ¥9.52B | - | - |